By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Atopix Pharmaceuticals Corporation 

2221 Las Palmas Drive, Suite J

Carlsbad  California  92009  U.S.A.
Phone: 760-603-7680 Fax: 760-603-7685



Company News
Chiesi Farmaceutici SpA Pays $80 Million for Atopix 's Asthma Portfolio 11/21/2016 6:48:37 AM
Atopix Appoints Dr Andrew Zambanini As Chief Medical Officer 9/3/2015 6:22:34 AM
Atopix Secures Funding To Broaden Development Of CRTH2 Antagonists For TH2-Mediated Disease 6/17/2015 8:03:53 AM
Aratana Therapeutics (PETX) And Atopix Complete Global Licensing Agreement For Development And Commercialization Of Novel Atopic Dermatitis Program 10/13/2014 7:51:20 AM
Atopix Secures Funding From SR One To Advance Development Of CRTH2 Antagonists In Eosinophilic Disease 10/7/2014 8:35:19 AM
Atopix Shows Off Positive Phase 2b Results For Once Daily OC459 In Asthma 3/3/2014 6:56:37 AM
Atopix Recruits First Patient In Phase 2 Trial Of OC459 For Atopic Dermatitis 11/19/2013 8:03:46 AM
Atopix Awarded Biomedical Catalyst Grant to Study an Innovative Anti-Allergic Approach to the Treatment of Atopic Dermatitis 5/29/2013 11:07:12 AM